Two Siblings With Microcephalic Osteodysplastic Primordial Dwarfism Type II (MOPDII) Caused by Compound Heterozygous Pericentrin (PCNT) Gene Variants

Microcephalic osteodysplastic primordial dwarfism type II (MOPDII) is a rare genetic disorder characterized by severe pre- and postnatal growth failure and microcephaly. We present two male siblings with MOPDII confirmed by the identification of compound heterozygous variants in the pericentrin (PCNT) gene. The first, a twin with intrauterine growth restriction, was diagnosed postnatally at four years of age after developing dysmorphic features and neurodevelopmental delays. His younger sibling was diagnosed prenatally via chorionic villus sampling. These cases highlight that MOPDII can result from compound heterozygous inheritance and underscore the importance of considering this diagnosis in severe, symmetric intrauterine growth restriction. A structured, multidisciplinary approach is essential for managing the complex comorbidities, including the high risk of cerebrovascular disease.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-12-24
DOI
https://doi.org/10.7759/cureus.99990
Primary Topic
Moyamoya disease diagnosis and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Two Siblings With Microcephalic Osteodysplastic Primordial Dwarfism Type II (MOPDII) Caused by Compound Heterozygous Pericentrin (PCNT) Gene Variants

Tarek El-Alem, Lina Abdullah, Ahmed Al Farsi, Amr Khalil
Cureus
Moyamoya disease diagnosis and treatment
article

Two Siblings With Microcephalic Osteodysplastic Primordial Dwarfism Type II (MOPDII) Caused by Compound Heterozygous Pericentrin (PCNT) Gene Variants

Tarek El-Alem, Lina Abdullah, Ahmed Al Farsi, Amr Khalil
article en

Abstract

Microcephalic osteodysplastic primordial dwarfism type II (MOPDII) is a rare genetic disorder characterized by severe pre- and postnatal growth failure and microcephaly. We present two male siblings with MOPDII confirmed by the identification of compound heterozygous variants in the pericentrin (PCNT) gene. The first, a twin with intrauterine growth restriction, was diagnosed postnatally at four years of age after developing dysmorphic features and neurodevelopmental delays. His younger sibling was diagnosed prenatally via chorionic villus sampling. These cases highlight that MOPDII can result from compound heterozygous inheritance and underscore the importance of considering this diagnosis in severe, symmetric intrauterine growth restriction. A structured, multidisciplinary approach is essential for managing the complex comorbidities, including the high risk of cerebrovascular disease.

CureusVol. 17(12)
Qatar Airways (Qatar) (QA), London Health Sciences Centre (CA), Sidra Medical and Research Center (QA), Hamad Medical Corporation (QA)
Hamad Medical Corporation
Good health and well-being
Openalex Percentile: Top 28%
Moyamoya disease diagnosis and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.